Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naive and Sensitized BALB/c Mice |
Chaudhary, Neelkamal
(Institute of Genomics and Integrative Biology)
Mahajan, Lakshna (Institute of Genomics and Integrative Biology) Madan, Taruna (Institute of Genomics and Integrative Biology) Kumar, Anil (School of Biotechnology, Devi Ahilya Vishwavidyalaya) Raghava, Gajendra Pratap Singh (Institute of Microbial Technology) Katti, Seturam Bandacharya (Biopolymers Division, Central Drug Research Institute) Haq, Wahajul (Biopolymers Division, Central Drug Research Institute) Sarma, Puranam Usha (Institute of Genomics and Integrative Biology) |
1 | von Garnier C, Astori M, Kettner A, Dufour N, Heusser C, Corradin G, Spertini F: Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis. Eur J Immunol 30;1638-1645, 2000 DOI ScienceOn |
2 | Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM: Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 88;27-32, 1991 DOI |
3 | Simon-Nobbe B, Denk U, Poll V, Rid R, Breitenbach M: The spectrum of fungal allergy. Int Arch Allergy Immunol 145;58-86, 2008 DOI ScienceOn |
4 | Finkelman FD, Katona IM, Mosmann TR, Coffman RL: IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 140;1022-1027, 1988 |
5 | Kozutsumi D, Tsunematsu M, Yamaji T, Murakami R, Yokoyama M, Kino K: Cry-consensus peptide, a novel peptide for immunotherapy of Japanese cedar pollinosis, induces Th1-predominant response in Cry j 1-sensitized B10.S mice. Biol Pharm Bull 29;2506-2509, 2006 DOI ScienceOn |
6 | Yoshitomi T, Nakagami Y, Hirahara K, Taniguchi Y, Sakaguchi M, Yamashita M: Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice. J Pept Sci 13;499-503, 2007 DOI ScienceOn |
7 | Helbling A, Reimers A: Immunotherapy in fungal allergy. Curr Allergy Asthma Rep 3;447-453, 2003 DOI ScienceOn |
8 | Crameri R, Weichel M, Fluckiger S, Glaser AG, Rhyner C: Fungal allergies: a yet unsolved problem. Chem Immunol Allergy 91;121-133, 2006 |
9 | Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR: Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 178;1783-1788, 1993 DOI ScienceOn |
10 | Kay AB, Larche M: Allergen immunotherapy with cat allergen peptides. Springer Semin Immunopathol 25;391-399, 2004 DOI ScienceOn |
11 | Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97;77-89, 1968 |
12 | Alexander C, Ying S, B Kay A, Larche M: Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy 35;52-58, 2005 DOI ScienceOn |
13 | Astori M, von Garnier C, Kettner A, Dufour N, Corradin G, Spertini F: Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. J Immunol 165;3497-3505, 2000 DOI |
14 | Hall G, Houghton CG, Rahbek JU, Lamb JR, Jarman ER: Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production. Vaccine 21;549-561, 2003 DOI ScienceOn |
15 | Nigam S, Ghosh PC, Sarma PU: Altered immune response to liposomal allergens of Aspergillus fumigatus in mice. Int J Pharm 236;97-109, 2002 DOI |
16 | Zhang GL, Srinivasan KN, Veeramani A, August JT, Brusic V: PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res 33;W180-W183, 2005 DOI ScienceOn |
17 | Bhasin M, Raghava GP: Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22;3195-3204, 2004 DOI ScienceOn |
18 | Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, Reid KB, Sarma PU: Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 107;467-475, 2001 DOI ScienceOn |
19 | Moser M, Crameri R, Menz G, Schneider T, Dudler T, Virchow C, Gmachl M, Blaser K, Suter M: Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. J Immunol 149;454-460, 1992 |
20 | Kamal N, Chowdhury S, Madan T, Sharma D, Attreyi M, Haq W, Katti SB, Kumar A, Sarma PU: Tryptophan residue is essential for immunoreactivity of a diagnostically relevant peptide epitope of A. fumigatus. Mol Cell Biochem 275; 223-231, 2005 DOI |
21 | Svirshchevskaya E, Frolova E, Alekseeva L, Kotzareva O, Kurup VP: Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice. Peptides 21;1-8, 2000 DOI ScienceOn |
22 | Svirshchevskaya EV, Alekseeva LG, Titov VM, Frolova EG, Sapozhnikov AM: Determination of T and B Cell Epitopes of Aspergillus fumigatus Ribotoxin and Heat Shock Protein. Russ J Immunol 3;61-68, 1998 |
23 | Bhasin M, Raghava GP: SVM based method for predicting HLA-DRB* 0401 binding peptides in an antigen sequence. Bioinformatics 20;421-423, 2004 DOI ScienceOn |
24 | Ramadan G, Davies B, Kurup VP, Keever-Taylor CA: Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol 140;81-91, 2005 DOI ScienceOn |
25 | Ramadan G, Davies B, Kurup VP, Keever-Taylor CA: Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol 139;257-267, 2005 DOI ScienceOn |
26 | Arruda LK, Mann BJ, Chapman MD: Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. J Immunol 149;3354-3359, 1992 |
27 | Madan T, Priyadarsiny P, Vaid M, Kamal N, Shah A, Haq W, Katti SB, Sarma PU: Use of a synthetic peptide epitope of Asp f1, a major allergen or antigen of Aspergillus fumigatus, for improved immunodiagnosis of allergic broncho-pulmonary aspergillosis. Clin Diagn Lab Immunol 11;552-558, 2004 |
28 | Kurup VP, Banerjee B, Murali PS, Greenberger PA, Krishnan M, Hari V, Fink JN: Immunodominant peptide epitopes of allergen, Asp f1 from the fungus Aspergillus fumigatus. Peptides 19;1469-1477, 1998 DOI ScienceOn |
29 | Madan T, Arora N, Sarma PU: Ribonuclease activity dependent cytotoxicity of Asp fl, a major allergen of A. fumigatus. Mol Cell Biochem 175;21-27, 1997 DOI |
30 | Madan T, Arora N, Sarma PU: Identification and evaluation of a major cytotoxin of A. fumigatus. Mol Cell Biochem 167;89-97, 1997 DOI |
31 | Tabar AI, Lizaso MT, Garcia BE, Gomez B, Echechipia S, Aldunate MT, Madariaga B, Martinez A: Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr Allergy Immunol 19;67-75, 2008 |
32 | Chauhan B, Knutsen A, Hutcheson PS, Slavin RG, Bellone CJ: T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 97;2324-2331, 1996 DOI ScienceOn |
33 | Lizaso MT, Tabar AI, Garcia BE, Gomez B, Algorta J, Asturias JA, Martinez A: Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters. Pediatr Allergy Immunol 19;76-81, 2008 |
34 | Malling HJ, Djurup R: Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium. Allergy 43;60-70, 1988 DOI ScienceOn |
35 | Senti G, Johansen P, Martinez Gomez J, Prinz Varicka BM, Kundig TM: Efficacy and safety of allergen-specific immunotherapy in rhinitis, rhinoconjunctivitis, and bee/wasp venom allergies. Int Rev Immunol 24;519-531, 2005 DOI ScienceOn |
36 | Akdis CA, Akdis M: Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123;735-746, 2009 DOI ScienceOn |
37 | Ajduk J, Marinic I, Aberle N, Rabatic S, Gagro A: Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children. Ann Allergy Asthma Immunol 100;314-323, 2008 DOI |
38 | Pfaar O, Klimek L: Anaphylaxis--life-threatening allergic reactions. MMW Fortschr Med 150;35-39, 2008 |
39 | Pfaar O, Klimek L: Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial. Ann Allergy Asthma Immunol 100;256-263, 2008 DOI |
40 | Eaton T, Garrett J, Milne D, Frankel A, Wells AU: Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 118;66-72, 2000 DOI ScienceOn |
41 | Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6; 761-771, 2006 DOI ScienceOn |
42 | Akdis M, Akdis CA: Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119;780-791, 2007 DOI ScienceOn |
43 | Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G: Participants in the Cystic Fibrosis Foundation Consensus Conference: Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 37(Suppl 3);S225-S264, 2003 DOI |
44 | Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A, Maillere B: HLA-DR restricted peptide candidates for bee venom immunotherapy. J Immunol 164;3177-3184, 2000 DOI |
45 | Zander DS: Allergic bronchopulmonary aspergillosis: an overview. Arch Pathol Lab Med 129;924-928, 2005 |
46 | Tillie-Leblond I, Tonnel AB: Allergic bronchopulmonary aspergillosis. Allergy 60;1004-1013, 2005 DOI ScienceOn |
47 | Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, Zak-Nejmark T, Koga R, Kobayashi T, Blaser K, Akdis CA: Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413;420-425, 2001 DOI ScienceOn |
48 | Johansen P, Senti G, Maria Martinez Gomez J, Kundig TM: Medication with antihistamines impairs allergen-specific immunotherapy in mice. Clin Exp Allergy 38;512-519, 2008 DOI ScienceOn |
49 | Jutel M, Blaser K, Akdis CA: Histamine receptors in immune regulation and allergen-specific immunotherapy. Immunol Allergy Clin North Am 26;245-259, 2006 DOI ScienceOn |
50 | Mehra NK, Verduijn W, Taneja V, Drabbels J, Singh SP, Giphart MJ: Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population. Hum Immunol 32;246-253, 1991 DOI ScienceOn |
51 | Kurup VP, Murali PS, Guo J, Choi H, Banerjee B, Fink JN, Coffman RL: Anti-interleukin (IL)-4 and -IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 52;1215-1221, 1997 DOI ScienceOn |
52 | Romani L: Immunity to fungal infections. Nat Rev Immunol 4;1-23, 2004 DOI |
53 | Bettelli E, Kuchroo VK: IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J Exp Med 201;169-171, 2005 DOI ScienceOn |
54 | Jutel M, Klunker S, Akdis M, Malolepszy J, Thomet OA, Zak-Nejmark T, Blaser K, Akdis CA: Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol 124;190-192, 2001 DOI ScienceOn |
55 | Rak S, Lowhagen O, Venge P: The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 82;470-480, 1988 DOI |
56 | Hamelmann E, Wahn U, Gelfand EW: Role of the Th2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness. Int Arch Allergy Immunol 118;90-94, 1999 DOI ScienceOn |